Anavex Life Sciences Corp.

AVXL · NASDAQ
Analyze with AI
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Assets
Cash & Equivalents$102,577$132,187$151,024$149,158
Short-Term Investments$0$0$0$0
Receivables$809$2,449$2,709$3,193
Inventory$0$0$0$0
Other Curr. Assets$429$931$653$354
Total Curr. Assets$103,815$135,567$154,386$152,705
Property Plant & Equip (Net)$0$0$0$0
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$3,362$3,546,742
Total NC Assets$0$0$3,362$3,546,742
Other Assets$0$0-$3,362-$3,546,742
Total Assets$103,815$135,567$154,386$152,705
Liabilities
Payables$4,249$9,627$4,322$3,825
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$805$842$0$444
Other Curr. Liab.$3,892$4,835$8,212$5,945
Total Curr. Liab.$8,946$15,304$12,534$10,214
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$0$0$0
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$8,946$15,304$12,534$10,214
Equity
Pref Stock$0$0$0$0
Common Stock$87$85$82$78
Retained Earnings-$382,448-$336,071-$293,069-$245,564
AOCI$0$0$0$0
Other Equity$477,230$456,249$434,839$387,977
Total Equity$94,869$120,263$141,852$142,491
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$103,815$135,567$154,386$152,705
Net Debt-$102,577-$132,187-$151,024-$149,158
Anavex Life Sciences Corp. (AVXL) Financial Statements & Key Stats | AlphaPilot